← Open Payments lookup

STEFANIE ROLLINS: Open Payments

NPI 1467780874 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,923 in 48 payments from 14 companies in 2025. Trend: 2023 $2,957 · 2024 $3,275 · 2025 $2,923

Food & beverage: $1,860Consulting: $1,055Education: $8
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.7$1,159
AstraZeneca Pharmaceuticals LP10$631
Genentech, Inc.2$283
GENZYME CORPORATION9$277
GlaxoSmithKline, LLC.6$199
Genentech USA, Inc.2$117
Optinose US, Inc.4$88
ARS Pharmaceuticals Operations, Inc.2$46
Novartis Pharmaceuticals Corporation1$29
Takeda Pharmaceuticals U.S.A., Inc.1$24

Products named: DUPIXENT, Xolair, TEZSPIRE, NUCALA, FASENRA, WAYRILZ, Xhance, NEFFY.

Industry payments across OK — which companies pay providers there.